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Living with global terrorism, global epidemics, and new 
medical technologies has made risk a dominant theme in the 
21st century in terms of both individual action and public 
policy. This condition has led us to become more occupied with 
debating, preventing, and managing risks. 
Risk Society, 1996 
Any time we read or watch the news, the global, scientifically 
saturated nature of the world becomes apparent. Current events 
pertaining to medical risks in particular have become increasingly 
significant. Take, for example, the recent Ebola situation in which 
we have witnessed how infectious disease threat and 
communication of risk ignite and stoke public frenzy about how to 
act and whom to blame. Think of the news coverage on whether the 
“infected Dallas nurse
and other innocent bystanders vulnerable to contracting Ebola. 
Also consider the treatment
politically issued–
went for a bike ride. 
Perceptions of harm get encased in public talk where 
case scenario” storylines not only dominate and d
but also lead to action. In this regard, and in response to her 
quarantine orders specifically, the 
 
 
 
 
 
Paso 
 
 
 
) 
–Ulrich Beck, 
 
” did or did not follow “protocol” leaving her 
 of the nurse in Maine who defied 
not medically issued–“quarantine orders” and 
 
“worst 
irect discussion 
“Maine nurse,” Kaci Hickox, 
World 
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argued that the U.S. would be better served by “evidence-based 
policies,” not “knee-jerk reactions” fueled by fear (Worland, 2014). 
As a society, we work hard to “anticipate and control [risks] 
(rhetorically and otherwise)” (Scott, 2012, 30). We do this even 
though risk is always about possibility and, therefore, is an 
unpredictable, uncontrollable combination of cultural perceptions, 
rhetorical constructions, and material effects (Beck, 1999; see also 
Douglas and Wildavsky, 1982; Kasperson and Kasperson, 2005; 
Scott, 2012).  
Despite its slippery ambiguity, we propose that risk must be 
managed in ways that account for these cultural perceptions, 
rhetorical constructions, and their impact on stakeholders. The 
presentations in this panel focused on three interrelated roles of 
rhetoric in shaping and managing medical risk: articulation, 
negotiation, and leveraging. We argued that viewing Beck's theory 
of reflexive modernization through a rhetorical lens, particularly in 
terms of agency, highlights his idea that modernization involves “a 
changing relationship between social structures and social agents” 
(Beck, 1992, 2).  
To unpack the rhetorical dynamics that regulate how we 
understand and act on risk (Dean 2000), we raised the following 
questions: How can medical risks and risk-management practices 
impact individual, social, and institutional identities? What roles do 
risks play in the generation, dis-assembling, and re-articulation of 
medical arguments, understandings, and relations? How can 
medical risks—as dynamic rhetorical constructions with material 
impacts—diffuse, destabilize, and otherwise complicate rhetorical 
agency? 
 
BIOANXIETY AND RISK MANAGEMENT 
In her presentation “Leveraging Risk and Advancing a Theory of 
Biotechnological Anxiety for Medicine’s Future,” Jennifer 
Malkowski characterized medical risks as taking place in an era of 
rapidly spreading and mutating viruses. Drawing from a 
Foucauldian-informed line of biosecurity studies, bioinsecurity 
studies, studies of biocitizenship, and theories of biomedicalization, 
Malkowski framed her argument around a concern she calls 
“bioanxiety” (Rosa and Novas, 2005; Rose, 2007; Lakoff and Collier 
2008; Klotz and Sylvester, 2009; Clarke et al., 2010; Keränen, 
2011). In her lexicon, bioanxiety refers to excessive worry about 
everyday living that is generated by the large, nebulous problems 
affiliated with biotechnological advancement, such as those related 
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to vaccination. Bioanxiety, Malkowski suggests, contributes to 
health experiences whereby members of various audiences are left 
with more questions than answers (e.g. “So now I know that I have 
multiple sclerosis, but the doctors don’t really know what causes or 
cures it or even what to expect in terms of how it will affect me 
personally?”), more concern than catharsis (e.g. “So now I know 
about bioterrorism, but what can I really do to protect myself?”) 
and, indelibly, evermore anxious about future health decisions (e.g. 
“If I decide to undergo genetic testing and find out I have ‘the 
breast cancer gene’ what action should I take next and what if that 
action poses immediate risks?”).  
Malkowski drew from political and professional communication 
concerning mandatory health care worker influenza vaccinations at 
both national and state levels and from evidence of the public 
backlash the issue has generated. Using these discourses, she 
illustrated how emotion, specifically anxiety, now animates much 
public discussion about risk response technologies, including 
vaccination. Her argument was that bioanxiety can be understood 
to describe the condition in which we (are made to) live. Convinced 
that vaccination talk impacts the material conditions of medical 
intervention and also social, political, and cultural realities, 
Malkowski noted that vaccination is a charged issue quite 
independent of the efficacy of any particular vaccine; both 
imminent and imagined disease threat inspire similar sorts of 
vaccination talk. Regardless of specific disease threats or 
intervention technology, concerns about vaccination-associated 
risks tend to assume a recognizable pattern: Expressions of concern 
about how vaccination infringes on human rights exposes financial 
incentive and inequities in health-care and troubles medicine’s 
relationship with nature. This pattern, according to Malkowski, 
foregrounds both the materiality and recalcitrant nature of 
biomedical intervention and the symbolic force of communication 
about such conditions. Currently that symbolic potential seems to 
be inspiring anxiety at the individual level, making one wonder if it 
may be inspiring anxiety at the collective level as well. In theorizing 
beyond the limits of the particular case of vaccination anxiety, 
Malkowski suggests that bioanxiety, as both a risk communication 
characteristic and consequence, may be leveraged in ways that turn 
attention back to common realties associated with risky living, a 
perspective that could mend troubled relationships between 
medicine and its publics. 
As Malkowski’s work illustrates, the relationship between 
medicine and its publics, which is characterized by an increase in 
disease threat awareness and a decrease in public trust in medicine, 
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creates tension for contemporary risk management practices. The 
pairing of threat and distrust breeds concern about the status of 
medicine more broadly and the nature of health care practices 
specifically, which causes unique problems for public health 
initiatives predicated on collective action. In this regard, 
recognition of bioanxiety as a common consequence of public 
deliberation about medical risk (rather than as an accurate 
reflection of the status of any particular disease risk or intervention 
efficacy) could foreground the collective, rhetorical agency available 
to us in all matters of preventative medicine, with vaccination 
serving as but one example. If we diagnose ourselves as suffering 
from a similar condition whose root cause is communicative in 
nature, we might mobilize that commonality and “suffering” to 
insist on changing how risk and responses to risk are discussed 
across contemporary settings. Such an outcome could influence the 
success of vital risk interventions. 
LIMINALITY IN DIABETES SELF-MANAGEMENT 
 
In “Negotiating Risk and Agency in Public Spaces of Chronic Care,” 
Lora Arduser argued that people with chronic illnesses present a 
microcosm from which we can examine the broader issue of living 
in a society of perpetual unpredictability and permanent liminality.  
A liminal situation, Agnes Horvath explains, is “any situation where 
borderlines and boundaries that previously were stable and taken 
for granted are dissolved” and “events happen that are never 
ending” (Horvath 2013, 10, 3). In the context of managing chronic 
and complex diseases, decision-making about risks has been 
characterized as embedded in uncertainty as well. Patients have to 
balance “a present known quality of life and an uncertain one in the 
future” (Barre, Beauchemain, Bocti, Broadbent, and Cohen, 2015, 
51). 
In her presentation, Arduser pointed to the case of people with 
diabetes as existing in a permanent state of liminality.  These 
individuals live with the anticipations of material risks. Their blood 
sugar may go too low. If so, they risk losing consciousness or going 
into seizures. At the same time, they are constantly bombarded with 
messages about the dangers of letting their blood sugar levels 
remain too high because these high numbers can lead to long-term 
risks of heart failure, blindness, kidney damage, and amputations. 
At the same time, the disease and the actions associated with 
managing (or mis-managing) diabetes invite symbolic risks that 
involve issues of identity and agency. Diabetics, particularly people 
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with type 2 diabetes, run the risk of being seen as uncontrolled, 
noncompliant, and lacking will power.  
Faced with material and symbolic risks, people with diabetes 
negotiate agency within a network of relationships in which they 
shift their orientations to their own bodies, other individuals, 
discourses, and knowledge. One example Arduser gave of this re-
negotiation of identity occurred during one of the focus groups she 
conducted with diabetics for her project. Over the course of 
discussion in this group, the participant who had been diabetic the 
longest established a “pack leader” identity. He responded first to 
each question, as others in the focus group seemed to defer to his 
expertise by readily giving him the floor. Yet, as he talked about his 
role in mentoring people in a diabetes online community, the same 
participant downplayed his expertise as a patient in his insistence 
of the importance of listening to the advice of medical 
professionals.  
Rhetorical agency as negotiation, Arduser argued, occurs in 
liminal spaces because in these spaces assumptions about power 
and authority can be challenged, including assumptions about 
patient expert identities and the narrative in which these identities 
perform. Such spaces encourage counter narratives about risk, the 
identity of “patient expert,” and the development and enactment of 
these counter narratives are an expression of rhetorical agency. In 
other words, the liminal and temporary nature of rhetorical agency 
in public spaces of chronic illness provides ways to negotiate 
physical and symbolic risks by enacting agency, questioning, 
challenging, reinterpreting, and renegotiating both discursive and 
material elements in these spaces. 
WHAT WORKS IN HIGH RISK SITUATIONS   
Lucia Dura gave another reading of the relational nature of risk, 
subjectivity, and agency in “What Works? What is Possible? 
Positive Deviance as a Rhetorical Flip in Risk Communication.” 
Dura looked at subjectivities in risk situations drawing on a case 
study focused specifically on health care associated infections 
(HAI).  She asked, “Who are we in this risk situation?” Some 
options she suggested were ‘vectors of infection,’ ‘infected or 
diseased,’ ‘in danger,’ ‘vulnerable,’ and ‘dangerous.’ Based on these 
subjectivities in the context of HAI, risk is usually addressed by 
technical directives such as instructions for proper hand washing, 
punitive action for non-compliance, or pharmaceutical 
intervention. Dura postulated that because of our tendency to focus 
on the problem and barriers to success, existing positive outcomes 
and successful behaviors are often ignored. She proposed a 
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rhetorical shift in the face of intractable issues, such as HAIs, 
through the positive deviance approach: What is working when it 
shouldn’t be working? 
Positive deviance questions normative ways of thinking, 
particularly the “norm” in the bell curve. Nassim Nicholas Taleb, in 
writing about the pitfalls of relying too heavily on the bell curve in 
social spheres, argued that the bell curve glorifies mediocrity, 
disregarding the promise lurking in large deviations and outliers 
(Taleb, 2007).  The positive deviance approach enables the 
identification of outliers as a starting point. Then, Dura explained, 
through rhetorical action positive deviance facilitates the discovery 
of outliers’ successful, replicable, and uncommon behaviors and 
practices. Positive deviants “lurk” at all organizational levels, e.g., 
frontline health providers, cleaning staff, and even patients and 
their families. The discovery of solutions to intractable problems, 
such as HAI in healthcare settings, by individuals “just like me” is 
empowering not just for outliers themselves, but also for their 
peers. Such emphasis on local assets brings with it peer-to-peer 
learning, local ownership of solutions, and a focus on 
relationships—in essence, culture change. 
Dura argued that positive deviance offers rhetoric and 
communication scholars a new lens through which to view the 
articulation of risk and to facilitate agency. By focusing on bright 
spots in risk situations, Dura explained, we leverage assets and 
create spaces for the construction of new positive narratives that 
affect individual and collective identities in risk situations. Scholars 
and practitioners can use positive deviance as an inventional 
framework for research or as a performative interventional strategy 
for social and organizational change.  The methodology has been 
applied to risk in a variety of contexts, e.g., education (persistence 
and graduation); exploitation of vulnerable populations (trafficking 
and reintegration of child soldiers); public health (self-
management, disease prevention, female genital cutting); and 
mental health (resilience). Still, positive deviance is not a “magic 
bullet.” Dura discussed several challenges:  Positive deviance 
requires an investment of time and social capital, necessitates belief 
in the value of local expertise, and can be challenging to present to 
scientists and technical experts because of its relational nature. 
Nonetheless, in concordance with her fellow panelists, Dura 
highlighted the potential of rhetorical concepts for acting 
heuristically to aid various publics in imagining otherwise when it 
comes to matters of risk and such communication.  
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CONCLUSION 
This panel highlighted the pressing need for rhetoricians of science 
and medicine to address complexity, uncertainty, and ambiguity as 
they relate to contemporary risk responses. We approached this 
challenge by (1) recognizing that cultural perceptions and rhetorical 
constructions of risk derive their power more from anticipation 
than from actualization; (2) critically examining the functions of 
dominant risk constructions; and (3) proposing alternative 
constructions, particularly with agency1 in mind.  We discussed risk 
situations in contemporary health and medicine as existing in a 
biological state of vague apprehension, a permanent liminal state of 
threat and uncertainty, and as an alternative accessible approach 
when a ‘normal’ way of doing things needs to make way for a ‘new 
normal’ in order to enact positive social change. These alternative 
frames, we argue, produce conditions whereby greater trust and 
fluency concerning risk communication enables the most 
vulnerable to live with a fuller degree of agency.  
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